Cargando…
Preoperative oral thyroid hormones to prevent euthyroid sick syndrome and attenuate myocardial ischemia-reperfusion injury after cardiac surgery with cardiopulmonary bypass in children: A randomized, double-blind, placebo-controlled trial
BACKGROUND: Both euthyroid sick syndrome and myocardial ischemia-reperfusion injury are common and have been significantly associated with morbidity and mortality after pediatric cardiac surgery with cardiopulmonary bypass. This single-center, prospective, double-blind, randomized placebo-controlled...
Autores principales: | Zhang, Jia-Qiang, Yang, Quan-Yong, Xue, Fu-Shan, Zhang, Wei, Yang, Gui-Zhen, Liao, Xu, Meng, Fan-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133632/ https://www.ncbi.nlm.nih.gov/pubmed/30200092 http://dx.doi.org/10.1097/MD.0000000000012100 |
Ejemplares similares
-
Euthyroid Sick Syndrome in Patients With COVID-19
por: Zou, Runmei, et al.
Publicado: (2020) -
Euthyroid sick syndrome in children with diabetic ketoacidosis
por: Hu, Yan-Yan, et al.
Publicado: (2015) -
Thyroid Hormone Profile in Children with Sepsis: Does Euthyroid Sick Syndrome Exist?
por: Yanni, Gema Nazri, et al.
Publicado: (2019) -
Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass
por: Veres, Gábor, et al.
Publicado: (2015) -
Deficiency of Interleukin-36 Receptor Protected Cardiomyocytes from Ischemia-Reperfusion Injury in Cardiopulmonary Bypass
por: Luo, Cheng, et al.
Publicado: (2020)